Formulation and Optimization of Taste-Masked Phenobarbitone Orally Disintegrating Tablets Prepared by Direct Compression Method
No Thumbnail Available
Date
2015-05
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Addis Ababa University
Abstract
Epilepsy is a serious neurological disorder characterized by spontaneous seizures.
Despite the development of successive generations of antiepileptic drugs,
phenobarbitone has retained a unique position in the therapeutic armamentarium
and is still the most widely prescribed drug for treatment of epilepsy throughout the
world. However, the pharmaceutical industry supplies oral solid dosage forms that
are generally inadequate for pediatric, geriatrics and patients experiencing difficulty
in swallowing needs. Therefore, the present study aims at formulation and
optimization of taste-masked orally disintegrating tablets of phenobarbitone using
direct compression technique for use in specific population such as pediatrics,
geriatrics and dysphagia patients. Thus, the study begins with the determination of
the bitterness threshold of phenobarbitone in vivo. Then, taste-masked microspheres
of phenobarbitone were prepared by oil in water emulsion solvent evaporation
technique using Eudragit®E100 as a polymeric material.
The effect of formulation variable i.e., polymer: drug ratio at four different levels
(1:1, 2:1, 3:1 and 4:1) and process variable, i.e., stirring rate (500, 650 and 800 rpm)
were examined. The prepared formulations were characterized for flow properties,
particle size distribution, entrapment efficiency and percentage yield. The study
revealed that the mean particle size ranged from 386.01 ± 3.88 to 456.72 ± 3.53 μm,
the drug encapsulation efficiency varied from 88.50 ± 2.14 to 97.00 ± 1.26% of the
theoretical amount incorporated. The taste-masking efficiency was determined by
spectrophotometric analysis based on the amount of drug released from tastemasked
microspheres in pH 6.8 phosphate buffer after 5 min. Taste evaluation
studies confirmed that microspheres of phenobarbitone having a polymer: drug ratio
of 1:1 are tasteless. FT-IR spectra of phenobarbitone and the physical mixture of
drug and Eudragit®E100 1:1 suggested no interaction between the drug and
polymer.
x
The effect of various formulation and process variable on phenobarbitone orally
disintegrating tablets was investigated. The results of the experiments revealed that
the major factors that affect the tablet characteristics are compression force, level of
superdisintegrant and MCC/mannitol. Besides, since it has significant effect on
drug release, the effect of polymer to drug ratio within the microsphere on the
various tablet characteristics was also investigated. Thus, four factors, two level (2
4-1) fractional factorial experimental design was selected to investigate the effects of
the selected independent variables on the various responses such as disintegration
time, wetting time, hardness, drug release in 5 min and drug release in 15 min of
taste-masked orally disintegrating tablets (ODTs). Accordingly, the various models
describing the relationship of the selected variables were obtained using Design-
Expert 8.0.7.1 software and the models were analyzed. The corresponding surface
response and contour plots were also obtained and the optimum area was
determined and, finally, the optimum was validated.
Simultaneous optimization of the responses gave the most desirable representative
optimum formulation, within the common optimum region, with a disintegration
time of 31.95 sec., wetting time of 46.41 sec., hardness of 52.13 N, drug release
within 5 min 62.21%,and drug release within 15 min of 90.03% at compression
force 11.29 KN, SSG of 4.6%, MCC/ mannitol ratio of 1.6 :1 and polymer to drug
ratio of 1.26:1. The validity of obtained optimal point was confirmed by the low
magnitude of percent prediction error.
Key words: phenobarbitone, Orally disintegrating tablets, Eudragit®E100, Tastemasking,
direct compression, Fractional factorial design
Description
Keywords
Phenobarbitone; Orally disintegrating tablets; Eudragit®E100; Tastemasking; Direct compression; Fractional factorial design